Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $32000.0.

  • Utah Medical Products' Change in Account Payables fell 8036.81% to $32000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$233000.0, marking a year-over-year decrease of 14804.12%. This contributed to the annual value of -$73000.0 for FY2024, which is 8399.12% up from last year.
  • Per Utah Medical Products' latest filing, its Change in Account Payables stood at $32000.0 for Q3 2025, which was down 8036.81% from -$180000.0 recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Change in Account Payables registered a high of $695000.0 during Q1 2022, and its lowest value of -$826000.0 during Q3 2023.
  • Moreover, its 5-year median value for Change in Account Payables was $32000.0 (2025), whereas its average is -$1000.0.
  • As far as peak fluctuations go, Utah Medical Products' Change in Account Payables crashed by 30229.01% in 2021, and later skyrocketed by 126274.51% in 2022.
  • Over the past 5 years, Utah Medical Products' Change in Account Payables (Quarter) stood at -$265000.0 in 2021, then skyrocketed by 71.32% to -$76000.0 in 2022, then surged by 436.84% to $256000.0 in 2023, then plummeted by 217.97% to -$302000.0 in 2024, then surged by 110.6% to $32000.0 in 2025.
  • Its Change in Account Payables was $32000.0 in Q3 2025, compared to -$180000.0 in Q2 2025 and $217000.0 in Q1 2025.